LOPERAMID Mepha lingual cpr orodisp 2 mg 20 pce
7680683250010
CH-68325
A07DA03
04.09.0.
1 / 3
google
Details
- Product number
- 6832501
- CPT
- -
- Packaging group
- 20
- Unit
- Tablette(n)
- Composition
- loperamidi hydrochloridum 2.00 mg, carmellosum natricum conexum corresp. natrium 0.45 mg, aspartamum 5.00 mg, aromatica (Früchte und Banane) cum saccharum 13-18 µg, magnesii stearas, mannitolum, pro compresso.
Articles (1)
Loperamid-Mepha lingual 2 mg, Schmelztabletten
Schmelztabletten
20
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
2.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
0.45 MG | Substance | HBESI |
|
(N/A)
|
5.0 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | AROMA |
|
(N/A)
|
- | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Authorization holder
Mepha Pharma AG
4051 Basel
Authorization information
- Swissmedic authorization number
- 68325
- Drug name
- Loperamid-Mepha lingual, Schmelztabletten
- Galenic form
- SCHM
- ATC Code
- A07DA03
- Authorization status
- Z
- Dispensation category
- D
- First authorization
- 17/03/2022
- Authorization expiration date
- 16/03/2027
- IT number
- 04.09.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- LOPERAMID Mepha lingual cpr orodisp 2 mg 20 pce
- Description (DE)
- LOPERAMID Mepha lingual Schmelztabl 2 mg 20 Stk
- Market launch
- 17/03/2022
- Narcotic (BTM)
- No